Search Results - sars-cov-2

PubPharm (4.404)

1

COVID-19: Human Epidemiology and Response to SARS-CoV-2 : Human Epidemiology and Response to SARS-CoV-2 (DAIT-COVID-19-001)

in: ClinicalTrials.gov | 2023

2

COVID-19 Associated Lymphopenia Pathogenesis Study in Blood : COVID-19-associated Lymphopenia Pathogenesis Study in Blood

in: ClinicalTrials.gov | 2023

3

Sequelae of Sars-CoV-2 Infections : Long-term Sequelae of Severe Sars-CoV-2 Infections

in: ClinicalTrials.gov | 2023

4

"NORPLASMA" Covid-19 Convalescent Plasma Treatment Monitoring Study : Covid-19 Convalescent Plasma Used for Treatment of Patients in Norway - a Monitoring Study

in: ClinicalTrials.gov | 2023

5

Consequences of COVID 19 Pandemic on Childhood Asthma : Consequences of SARS-CoV2 Pandemic on Childhood Asthma Control and Exacerbations: French Multicenter Cross-sectional VIRASTHMA COVID G4 Study

in: ClinicalTrials.gov | 2023

6

Community-engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations : Community-engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations

in: ClinicalTrials.gov | 2023

7

Novel Experimental COVID-19 Therapies Affecting Host Response : CONNECTS Master Protocol for Clinical Trials Targeting Macro-, Micro-immuno-thrombosis, Vascular Hyperinflammation, and Hypercoagulability and Renin-angiotensin-aldosterone System (RAAS) in Hospitalized Patients With COVID-19 (ACTIV-4 Host Tissue)

in: ClinicalTrials.gov | 2023

8

Effects of Post-COVID-19 on Quadriceps Femoral Muscle-tendon Unit : Effects of Post-COVID-19 on Neural Activation and Architecture of the Quadriceps Femoral Muscle-tendon Unit and Its Correlation With Inflammatory Markers

in: ClinicalTrials.gov | 2023

9

Clinical Performance Evaluation of the NeuMoDx™ FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 Assay : Multi-Center Clinical Performance Evaluation of the NeuMoDx™ FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 Assay on the NeuMoDx™ Molecular Systems

in: ClinicalTrials.gov | 2023

10

Efficacy of Breathox Device Inhalation Therapy in the Treatment of Acute Symptoms Associated With COVID-19 and in the Prevention of the Use of Health Resources : Randomized, Open-label Study to Evaluate the Efficacy of Breathox Device Inhalation Therapy in the Treatment of Acute Symptoms Associated With COVID-19 and in the Prevention of the Use of Health Resources in Patients With ≥ 18 Years Old

in: ClinicalTrials.gov | 2023

1
2
3
4
5
6
7
8
9
10
11
Next »
[441]